Thermo Fisher Scientific Inc. (NYSE: TMO) has reported its financial results for the second quarter of 2025, showcasing a blend of positive growth and challenges.
Key Financial Metrics:
Revenues:
Q2 2025: $10.855 billion, up 3% from Q2 2024 revenue of $10.541 billion.
YTD 2025: $21.219 billio...